GTX medical BV and NeuroRecovery Technologies Inc. Merge to Create Leading Neurostimulation Company for Spinal Cord Injury

GTX medical BV and NeuroRecovery Technologies Inc. Merge to Create Leading Neurostimulation Company for Spinal Cord Injury

Eindhoven, NL and Lausanne, CH; Los Angeles, USA; October 22, 2019 – GTX medical BV (‘GTX’, formerly known as G-Therapeutics) and NeuroRecovery Technologies Inc. (‘NRT’) today announced their merger to create a leading global company committed to developing novel neuromodulation therapies to improve functional recovery of people with Spinal Cord Injuries (SCI). The merged entity will be known as GTX medical BV. The Christopher & Dana Reeve Foundation, the premier North American nonprofit organization dedicated to curing spinal cord injury by advancing innovative research and improving quality of life for people living with paralysis, will be a shareholder in the merged company, alongside current investors including LSP, Inkef, Wellington Partners and Gimv. Ian Curtis, board member of the Reeve Foundation, will join the Board of Directors.